Mathematical Prognostic Biomarker Models for Treatment Response and survival in Epithelial Ovarian Cancer
Following initial standard chemotherapy (platinum/taxol), more than 75% of those patients with advanced stage epithelial ovarian cancer (EOC) experience a recurrence. There are currently no accurate prognostic tests that, at the time of the diagnosis/surgery, can identify those patients with advance...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2011-01-01
|
| Series: | Cancer Informatics |
| Online Access: | https://doi.org/10.4137/CIN.S8104 |